Ivan V. Klyuchnikov

Ivan V. Klyuchnikov

Auto-generated profile, based on publicly available information

Ivan V. Klyuchnikov

Bakulev National Medical Research Center for Cardiovascular Surgery; Russian Medical Academy of Continuous Professional Education

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Clinical Microbiology and Antimicrobial Chemotherapy
Verified
Journal Article
Open access
AZAndrey A. Zaitsev
Andrey A. Zaitsev
EGE.Z. Golukhova
E.Z. Golukhova
MMMaxim Mamalyga
Maxim Mamalyga
SCS.A. Chernov
S.A. Chernov
MRM.M. Rybka
M.M. Rybka
IOI.N. Orlov
I.N. Orlov
Objective. To assess efficacy and safety of methylprednisolone pulse therapy in patients with COVID-19. Materials and Methods. A retrospective analysis of 57 patients with moderate and severe novel coronavirus infection (COVID-19) receiving methylprednisolone pulse therapy (500 mg/day IV for 2–3 consecutive days) was performed. Pre- and post-therapy examination of the patients included clinical (severity and duration of fever, gas exchange parameters), imaging (computed tomography) and laboratory tests (including C-reactive protein, procalcitonin, D-dimer). Results. Methylprednisolone pulse therapy resulted in improved gas exchange (the mean duration of SpO2 recovery was 3.9 ± 0.25 days), body temperature normalization (the mean time to defervescence was 2.1 ± 0.2 days), significant decrease in inflammatory marker levels (CRP, D-dimer). No patients required an enhancement of respiratory support (transfer to ICU). Methylprednisolone pulse therapy was well-tolerated and did not cause bacterial complications. Conclusions. Methylprednisolone pulse therapy in patients with COVID-19 was shown to decrease activity of systemic inflammatory response, severity of coagulation disorders and contribute to recovery of gas exchange lung function. Given the high efficacy and low cost of methylprednisolone pulse therapy, it could be one of the promising approaches to the management of patients with moderate and severe COVID-19. Further studies are needed to determine prognostic criteria of progression and optimal time for initiation of corticosteroid therapy.

3 December 2020 in Kardiologiia
Verified
Journal Article
Closed access
PDF file
EGE. Z. Golukhova
E. Z. Golukhova
ISInessa Viktorovna Slivneva
Inessa Viktorovna Slivneva
MRM. M. Rybka
M. M. Rybka
MMMaxim Mamalyga
Maxim Mamalyga
DMDamir Marapov
Damir Marapov
DDD. A. Dibin
D. A. Dibin
Aim To analyze survival of patients with COVID-19 based on echocardiographic (EchoCG) criteria for evaluation of the right ventricular (RV) systolic function. Material and methods Data of patients were retrospectively evaluated at the Center for Medical Care of Patients with Coronavirus Infection. Among 142 primarily evaluated patients with documented COVID-19, 110 patients (men/women, 63/47; mean age, 62.3 ± 15.3 years) met inclusion/exclusion criteria. More than 30 EchoCG parameters were analyzed, and baseline data (comorbidities, oxygen saturation, laboratory data, complications, outcomes, etc.) were evaluated. ROC-analysis was used for evaluating the diagnostic significance of different EchoCG parameters for prediction of a specific outcome and its probability. Dependence of the overall survival of patients on different EchoCG parameters was analyzed with the Cox proportional hazards model. For assessing the predictive value of EchoCG parameters for patient stratification by risk of an adverse outcome, a predictive model was developed using the CHAID method. Results The in-hospital death rate of patients included into the study was 15.5 %, and the death rate for this period of in-hospital observation was 12 %. Based on the single-factor analysis of EchoCG parameters, a multifactor model was developed using the method of Cox regression. The model included two predictors for an unfavorable outcome, estimated pulmonary artery systolic pressure (EPASP) and maximal indexed right atrial volume (RAi), and a preventive factor, right ventricular global longitudinal strain (LS RV). Base risks for fatal outcome were determined with an account of the follow-up time. According to the obtained values, an increase in EPASP by 1 mm Hg was associated with increases in the risk of fatal outcome by 8.6 % and in the RA(i) volume by 1 ml/5.8 %. LS RV demonstrated an inverse correlation; a 1% increase in LS RV was associated with a 13.4% decrease in the risk for an unfavorable outcome. According to the ROC analysis, the most significant determinants of the outcome were the tricuspid annular plane systolic excursion (TAPSE) (AUC, 0.84 ± 0.06; cut-off, 18 mm) and EPASP (AUC, 0.86 ± 0.05; cut-off, 42 mm Hg). Evaluating the effects of different EchoCG predictors, that characterized the condition of the right heart, provided a classification tree. Six final decisions were determined in the model, two of which were assigned to the category of reduced risk for fatal outcome and four were assigned to the category of increased risk. Sensitivity of the classification tree model was 94.1 % and specificity was 89.2 %. Overall diagnostic significance was 90.0±2.9 %. Conclusion The presented models for statistical treatment of EchoCG parameters reflect the requirement for a comprehensive analysis of EchoCG parameters based on a combination of standard methods for EchoCG evaluation and current technologies of noninvasive visualization. According to the study results, the new EchoCG marker, LS RV, allows identifying the signs of right ventricular dysfunction (particularly in combination with pulmonary hemodynamic indexes), may enhance the early risk stratification in patients with COVID-19, and help making clinical decisions for patients with different acute cardiorespiratory diseases.

30 December 2020 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
EGE. Z. Golukhova
E. Z. Golukhova
ISInessa Viktorovna Slivneva
Inessa Viktorovna Slivneva
MRM. M. Rybka
M. M. Rybka
MMMaxim Mamalyga
Maxim Mamalyga
MAMikhail Nikolaevich Alekhin
Mikhail Nikolaevich Alekhin
DMDamir Marapov
Damir Marapov
Aim. To determine the predictive role of estimated pulmonary artery systolic pressure (ePASP) in COVID-19 patients.Material and methods. A retrospective study of inpatients with documented COVID-19 infection was carried out. Maximal follow-up period was 63 days. The study included 108 patients (men, 62; women, 46; mean age, 62,9±15,5 years). At admission, mean NEWS score was 6,0, blood oxygen saturation — 92%. Echocardiography was performed according to standard protocol using Vivid E9 ultrasound system (GE Healthcare). Quantitative measurements were performed according to the current ASE and EACVI guidelines. Statistical analysis was performed using the IBM SPSS Statistics v.26 software (developed by IBM Corporation).Results.Using the CHAID technique, a classification tree was developed and the strongest predictor of an unfavorable outcome was determined (ePASP). Threshold ePASP values, associated with an increased mortality risk were established (42 mm Hg and 50 mm Hg). Three groups of patients were selected based on the main predictor (50 mm Hg). The increased mortality risk was noted in groups 2 and 3 compared to group 1 of patients and amounted to 31,8% and 70% versus 3,9%, respectively. There was also a correlation between the severity of CT lung parenchymal lesions according to computed tomography and the study groups of patients (36% [30-49%] — group 1, 50% [36-76%] — group 2, and 84% [56-92%] — group 3, p=0,001). In groups 2 and 3, the following complications were significantly more frequent: acute respiratory distress syndrome, acute heart failure, multiple organ system failure, venous thrombosis, disseminated intravascular coagulation. In group 3, acute renal failure and systemic inflammatory response syndrome developed significantly more often than in group 1.Conclusion.A comprehensive echocardiography has proven its availability and safety in assessing the condition of COVID-19 patients, allowing to obtain relevant information on pulmonary hemodynamics. Transthoracic echocardiography reduced the risk of complications from invasive diagnostic methods and allowed to abandon the use of the Swan-Ganz pulmonary artery catheter in the studied group of patients. As a result, a relationship was noted between the increase of ePASP and the severity of clinical performance and lung tissue damage according to computed tomography, changes in laboratory blood tests, the severity of the comorbid profile, an increase in respiratory support need.

13 April 2024 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
ISI. V. Samorodskaya
I. V. Samorodskaya
IKI. V. Klyuchnikov
I. V. Klyuchnikov
RSR. N. Shepel
R. N. Shepel
EKE. P. Kakorina
E. P. Kakorina
ODOxana M. Drapkina
Oxana M. Drapkina
Aim. To assess regional variability of standardized mortality rates (SMRs) for men and women from three types of coronary artery disease (CAD) for 2 periods (2017-2019 and 2020-2022).Material and methods. Rosstat data on the average annual population and the number of deaths in one-year age groups for 82 constituent Russian entities were used. SMRs was calculated using software (state registration number 216661114) and the European Standard Population by the direct standardization per 100 thousand population. The average regional SMRs were calculated for 2017-2019 and 2020­2022 as follows: (I21-I22) myocardial infarction (MI); (I20, I24.1-9) other acute coronary artery disease types; (I25.0-9) chronic coronary syndromes; all 3 groups of CAD.Results. We found that the regional average CAD SMR among men (343,0±98,3 and 364,2±105,7 per 100 thousand population) is >2 times than among women (163,3±55,7 and 179, 5±61,2 per 100 thousand population), but men and women did not differ in the average regional proportion of CAD in the structure of all-cause mortality. In 5 regions, a simultaneous decrease in SMR from three CAD types and their total indicator was registered in both men and women; in 8, an increase in SMR was registered for each of the three forms and their sum, and in the remaining regions, multidirectional dynamics were noted. The coefficient of variation of regional MI SMR changes for men was 830%, for women — 322%; for other acute CAD — 7145% and 2523%, respectively. In general, the increase in CAD SMR occurred mainly due to an increase in SMR from chronic CAD against the background of a decrease in MI SMR. The proportion of chronic CAD in the structure of all CAD types is higher in women (80,1±11,9 and 82,9±10,3%) than in men (75,5±14 and 77,6±13%). The proportion of MI among men is 14,8±6,1 and 13,5±6,6%, among women — 7,1±10,9 and 6,2±8,7%.Conclusion. The pronounced variability of regional SMRs and their changes over time, differences in mortality structure between men and women indicate a number of unresolved statistical issues related to determining the initial cause of death from CAD and its individual types, including with multimorbid pathology.

13 February 2025 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
ISI. V. Samorodskaya
I. V. Samorodskaya
RSR. N. Shepel
R. N. Shepel
IKI. V. Klyuchnikov
I. V. Klyuchnikov
MLM. M. Lukyanov
M. M. Lukyanov
SMS. Yu. Martsevich
S. Yu. Martsevich
СМС. Ю. Марцевич
С. Ю. Марцевич
Aim. To study the possibilities of using electronic medical records in health information systems (HIS) to assess the demographic characteristics and nosological causes of visits to outpatient clinics and death (using myocardial infarction (MI) as an example).Material and methods. This retrospective study was conducted based on the registration of anonymized personalized data of electronic medical records from HIS of the Moscow Region and data on the underlying cause of death provided by the General Civil Registry Office of the Moscow Region. A total of 2357 people with acute MI in 20202021, which was the reason for visiting the clinic and/or the cause of death in 2021, were included in the study. Depending on the reason for visiting an outpatient clinic/the underlying cause of death, the study participants were divided into 4 following groups: group 1 — any cause except coronary artery disease (CAD) and MI/MI; group 2 — CAD but not MI/MI; group 3 — MI/not MI; group 4 — MI/MI. Statistical analysis was performed using the SPSS-26.0 program.Results. The mean age at death in group 2 was significantly higher than in groups 1, 3 and 4 (p<0,001). In all groups, the mean age at death in women was significantly higher than in men (p<0,001). The mean number of visits to outpatient clinics was highest among patients in group 3 (p<0,001). Among 1976 patients who died from MI in 2021 and had previously visited the clinic in 2020-2021 (groups 1, 2, 4), in 71,4% of cases the reason for visiting was not CAD. In 92 (3,9%) patients, MI was the reason for visiting in 2020-2021 and the initial cause of death in 2021, while in 1404 (59,6%) patients who did not visit for CAD or MI in 2020-2021, MI was the initial cause of death in 2021. Following data recording errors were revealed: only in 28 (12,7%) of 219 cases after MI were codes recommended in the International Statistical Classification of Diseases and Related Health Problems, 10th revision (ICD-10) for recording cases of post-infarction cardiosclerosis (I25.8) indicated; in 326 (16,5%) cases among those who died from MI, codes I22.0-9 were used, which are not recommended to be indicated as the underlying cause of death. Almost half of the cases indicated codes for MI of unspecified location. In group 1, diseases such as hypertension, cancer, and diabetes were registered less frequently. The proportion of cerebrovascular diseases was the lowest among patients in group 4. Hypertension, cerebrovascular diseases, acute cerebrovascular accident, cancer and COVID-19 were most frequently detected among patients in group 3, while diabetes was most frequently found in participants in group 2.Conclusion. The study results indicate barriers and problems in the use of accumulated data arrays in HIS. The data obtained confirm the need to develop measures aimed at standardization, structuring and a single regulatory system for entering data on the reasons for patient visits to outpatient clinics and the causes of their death in HIS. It also indicates the relevance of research analysis of HIS information in order to improve the stratification of the risk of adverse outcomes and increase the effectiveness of treatment and preventive care at the outpatient stage.

22 September 2023 in Clinical Medicine (Russian Journal)
Verified
Journal Article
Open access
PDF file
ISI. V. Samorodskaya
I. V. Samorodskaya
IKI. V. Klyuchnikov
I. V. Klyuchnikov
The level of mortality from ischemic heart disease (IHD) is infl uenced by a signifi cant number of factors. Objective. Assessment of the dynamics and variability of standardized mortality rates (SMR) from chronic IHD and acute forms of ischemic heart disease (AIHD) in the regions of the Russian Federation (RF) in 2013–2021. Material and methods. Data from Rosstat for 2013–2021 on the average annual population and number of deaths in one-year age groups in 82 regions of the RF based on the “Brief Nomenclature of Causes of Death of Rosstat” (BNCDR). SMRs were calculated based on the European standard per 100,000 population. Results. From 2013 to 2019, most regions showed an unstable trend towards a decrease in SMRs from chronic IHD, myocardial infarction (MI), and other AIHD (ICD codes — I20.0, I20.1–9), and an increase in SMRs in 2020 and 2021. The greatest decrease in SMRs was registered for other AIHD (40.2 ± 37.9 in 2013 and 20.5 ± 26.8 in 2021 per 100,000 of population). The coeffi cient of variation between regional SMRs for other AIHD was 120%, for MI — 45%, and for chronic IHD — 37%. Statistically signifi cant diff erences between 2021 and 2013 were found for SMRs from chronic IHD (225.3 ± 76.5 and 207.4 ± 76.9), other AIHD, but not for MI (38.2 ± 18.1 and 30.7 ± 14). Overall, the SMRs from all forms of IHD in 2021 exceeded the indicators of 2013 in 19 regions. The variability and dynamics of regional SMRs from diff erent forms of IHD may be due to both the possibilities and quality of preventive and therapeutic measures, as well as diff erent approaches to determining the cause of death. Conclusions. Most regions show unstable dynamics towards a decrease in SMRs from diff erent forms of IHD, and the obtained results require clarifi cation of the criteria for IHD as the underlying cause of death.